Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology



Chapter 2. Executive Summary


2.1. Global biologics outsourcing market, 2016 2024 (USD Million)

2.2. Global biologics outsourcing market: Snapshot



Chapter 3. Biologics outsourcing Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global biologics outsourcing market drivers: Impact analysis

3.2.2. Increasing RD spending on biologics drugs

3.2.3. Enormous cost time-saving advantages

3.3. Market Restraints


3.3.1. Global biologics outsourcing market restraints: Impact analysis

3.3.2. High technical requirement

3.4. Opportunities


3.4.1. Leverage outside technology

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat of new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by product segment

3.6.2. Market attractiveness analysis, by type segment

3.6.3. Market attractiveness analysis, by source segment

3.6.4. Market attractiveness analysis, by application segment

3.6.5. Market attractiveness analysis, by regional segment



Chapter 4. Global Biologics outsourcing Market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global biologics outsourcing market: company market share, 2016

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Therapy Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Therapy and Regional Expansion

4.3. Price Trend Analysis

4.4. Technology Portfolio



Chapter 5. Global Biologics outsourcing Market Product Segment Analysis


5.1. Global biologics outsourcing market: Product type overview


5.1.1. Global biologics outsourcing market revenue share, by Product, 2016 and 2024

5.2. Antibody


5.2.1. Global Antibody market, 2016 2024(USD Million)

5.2.2. Global Antibody market by monoclonal antibody, 2016 2024(USD Million)

5.2.3. Global Antibody market by Bi-specific Antibody, 2016 2024(USD Million)

5.2.4. Global Antibody market by Antibody Drug Conjugates, 2016 2024(USD Million)

5.3. Recombinant Protein


5.3.1. Global Recombinant Protein market , 2016 2024(USD Million)

5.4. Vaccines


5.4.1. Global Vaccines market , 2016 2024(USD Million)

5.5. Others


5.5.1. Global Others market , 2016 2024(USD Million)



Chapter 6. Global Biologics outsourcing Market Type Segment Analysis


6.1. Global biologics outsourcing market: Type overview


6.1.1. Global biologics outsourcing market revenue share, by Type, 2016 and 2024

6.2. Kits Reagents


6.2.1. Global Kits Reagents market , 2016 2024(USD Million)

6.3. Instruments


6.3.1. Global Instruments market , 2016 2024(USD Million)



Chapter 7. Global Biologics outsourcing Market Source Segment Analysis


7.1. Global biologics outsourcing market: Source overview


7.1.1. Global biologics outsourcing market revenue share, by Source, 2016 and 2024

7.2. Microbial


7.2.1. Global Microbial source market , 2016 2024(USD Million)

7.3. Mammalian


7.3.1. Global Mammalian source market , 2016 2024(USD Million)



Chapter 8. Global Biologics outsourcing Market Application Segment Analysis


8.1. Global biologics outsourcing market: Application overview


8.1.1. Global biologics outsourcing market revenue share, by application, 2016 2024

8.2. Vaccine Therapeutics Development


8.2.1. Global biologics outsourcing market for Vaccine Therapeutics Development, 2016 2024 (USD Million)

8.3. Blood Blood Related Products Testing


8.3.1. Global biologics outsourcing market for Blood Blood Related Products Testing, 2016 2024(USD Million)

8.4. Cellular and Gene Therapy


8.4.1. Global biologics outsourcing market for Cellular and Gene Therapy, 2016 2024 (USD Million)

8.5. Tissue and Tissue Related Products Testing


8.5.1. Global biologics outsourcing market for Tissue and Tissue Related Products Testing, 2016 2024 (USD Million)

8.6. Stem Cell Research


8.6.1. Global biologics outsourcing market for Stem Cell Research, 2016 2024 (USD Million)



Chapter 9. Global Biologics outsourcing Market Regional Segment Analysis


9.1. Global biologics outsourcing market: Regional overview


9.1.1. Global biologics outsourcing market revenue share, by region, 2016 and 2024

9.2. North America


9.2.1. North America biologics outsourcing market revenue, by Product, 2014 2024 (USD Million)

9.2.2. North America biologics outsourcing market revenue, by Type, 2014 2024 (USD Million)

9.2.3. North America biologics outsourcing market revenue, by Source, 2014 2024 (USD Million)

9.2.4. North America biologics outsourcing market revenue, by application, 2014 2024 (USD Million)

9.2.5. U.S.

9.2.6. Rest of North America

9.3. Europe


9.3.1. Europe biologics outsourcing market revenue, by Product, 2014 2024(USD Million)

9.3.2. Europe biologics outsourcing market revenue, by Type, 2014 2024(USD Million)

9.3.3. Europe biologics outsourcing market revenue, by Source, 2014 2024(USD Million)

9.3.4. Europe biologics outsourcing market revenue, by application, 2014 2024(USD Million)

9.3.5. Germany

9.3.6. UK

9.3.7. France

9.3.8. Italy

9.3.9. Spain

9.3.10. Russia

9.4. Asia Pacific


9.4.1. Asia Pacific biologics outsourcing market revenue, by Product, 2014 2024, (USD Million)

9.4.2. Asia Pacific biologics outsourcing market revenue, by Type, 2014 2024, (USD Million)

9.4.3. Asia Pacific biologics outsourcing market revenue, by Source, 2014 2024, (USD Million)

9.4.4. Asia Pacific biologics outsourcing market revenue, by application, 2014 2024, (USD Million)

9.4.5. China

9.4.6. Japan

9.4.7. India

9.4.8. South East Asia

9.4.9. Rest of Asia Pacific

9.5. Latin America


9.5.1. Latin America biologics outsourcing market revenue, by Product, 2014 2024(USD Million)

9.5.2. Latin America biologics outsourcing market revenue, by Type, 2014 2024(USD Million)

9.5.3. Latin America biologics outsourcing market revenue, by Source, 2014 2024(USD Million)

9.5.4. Latin America biologics outsourcing market revenue, by application, 2014 2024(USD Million)

9.5.5. Brazil

9.5.6. Rest of Latin America

9.6. Middle East and Africa


9.6.1. Middle East and Africa biologics outsourcing market revenue, by Product, 2014 2024 (USD Million)

9.6.2. Middle East and Africa biologics outsourcing market revenue, by Type, 2014 2024 (USD Million)

9.6.3. Middle East and Africa biologics outsourcing market revenue, by Source, 2014 2024 (USD Million)

9.6.4. Middle East and Africa biologics outsourcing market revenue, by application, 2014 2024 (USD Million)



Chapter 10. Company Profile


10.1. BoehringerIngelheim GmbH


10.1.1. Overview

10.1.2. Financials

10.1.3. Therapy portfolio

10.1.4. Business strategy

10.1.5. Recent developments

10.2. Catalent, Inc.


10.2.1. Overview

10.2.2. Financials

10.2.3. Therapy portfolio

10.2.4. Business strategy

10.2.5. Recent developments

10.3. GenScript


10.3.1. Overview

10.3.2. Financials

10.3.3. Therapy portfolio

10.3.4. Business strategy

10.3.5. Recent developments

10.4. Innovent Biologics, Inc.


10.4.1. Overview

10.4.2. Financials

10.4.3. Therapy portfolio

10.4.4. Business strategy

10.4.5. Recent developments

10.5. Syngene


10.5.1. Overview

10.5.2. Financials

10.5.3. Therapy portfolio

10.5.4. Business strategy

10.5.5. Recent developments

10.6. Shanghai MedicilonInc.


10.6.1. Overview

10.6.2. Financials

10.6.3. Therapy portfolio

10.6.4. Business strategy

10.6.5. Recent developments

10.7. GL Biochem Corporation Ltd.


10.7.1. Overview

10.7.2. Financials

10.7.3. Therapy portfolio

10.7.4. Business strategy

10.7.5. Recent developments

10.8. GVK Biosciences Private Limited


10.8.1. Overview

10.8.2. Financials

10.8.3. Therapy portfolio

10.8.4. Business strategy

10.8.5. Recent developments

10.9. Horizon Discovery Group plc.


10.9.1. Overview

10.9.2. Financials

10.9.3. Therapy portfolio

10.9.4. Business strategy

10.9.5. Recent developments

10.10. Albany Molecular Research Inc.


10.10.1. Overview

10.10.2. Financials

10.10.3. Therapy portfolio

10.10.4. Business strategy

10.10.5. Recent developments

10.11. Selexis SA


10.11.1. Overview

10.11.2. Financials

10.11.3. Therapy portfolio

10.11.4. Business strategy

10.11.5. Recent developments

10.12. Lonza


10.12.1. Overview



10.12.2. Financials

10.12.3. Therapy portfolio

10.12.4. Business strategy

10.12.5. Recent developments

10.13. Abzena PLC


10.13.1. Overview

10.13.2. Financials

10.13.3. Therapy portfolio

10.13.4. Business strategy

10.13.5. Recent developments

10.14. Adimab LLC.


10.14.1. Overview

10.14.2. Financials

10.14.3. Therapy portfolio

10.14.4. Business strategy

10.14.5. Recent developments

10.15. JHL BIOTECH, INC.


10.15.1. Overview

10.15.2. Financials

10.15.3. Therapy portfolio

10.15.4. Business strategy

10.15.5. Recent developments

10.16. ProteoGenix


10.16.1. Overview

10.16.2. Financials

10.16.3. Therapy portfolio

10.16.4. Business strategy

10.16.5. Recent developments

10.17. Sino Biological Inc.


10.17.1. Overview

10.17.2. Financials

10.17.3. Therapy portfolio

10.17.4. Business strategy

10.17.5. Recent developments

10.18. THE JACKSON LABORATORY


10.18.1. Overview

10.18.2. Financials

10.18.3. Therapy portfolio

10.18.4. Business strategy

10.18.5. Recent developments